Drug
Etavopivat clinical trials
Also written FT-4202.
- studies test it
- 11
- open now
- 2
- in phase 3
- 2
- first study started
- 2021
Keep track of what changes. Save the etavopivat studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
11 studies that test it; most in 2024 (4)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 4
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
Digoxin (1) · Pitavastatin (1) · Metformin (1) · Midazolam (1) · Rosuvastatin (1)
Studies
Open first, then newest update. How each study uses etavopivat is read from its arms, and is right about nine times in ten.
Testing it · 11
- A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell DiseaseRecruitingPhase 2Forma Therapeutics, Inc.NCT06198712Written as Etavopivat
- A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell DiseaseRecruitingPhase 3Novo Nordisk A/SNCT06612268Written as Etavopivat
- A Research Study of the Effect of Etavopivat on Other Drugs in Healthy ParticipantsCompletedPhase 1Novo Nordisk A/SNCT06813924Written as Etavopivat
- A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)TerminatedPhase 2Forma Therapeutics, Inc.NCT05568225Written as Etavopivat
- A Research Study on Etavopivat in Participants With and Without Liver DiseaseCompletedPhase 1Novo Nordisk A/SNCT06336018Written as Etavopivat
- Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell DiseaseCompletedPhase 2Novo Nordisk A/SNCT05725902Written as Etavopivat
- A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)Active, not recruitingPhase 3Forma Therapeutics, Inc.NCT04624659Written as Etavopivat Tablets Low dose
- A Study on the Effect of Etavopivat on Heart Rhythm in Healthy ParticipantsCompletedPhase 1Novo Nordisk A/SNCT07023029Written as Etavopivat
- A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese ParticipantsCompletedPhase 1Novo Nordisk A/SNCT06581627Written as Etavopivat
- A Study of Etavopivat in Patients With Thalassemia or Sickle Cell DiseaseCompletedPhase 2Forma Therapeutics, Inc.NCT04987489Written as Etavopivat tablets
- A Research Study of the Effect of Food on Etavopivat in Healthy ParticipantsCompletedPhase 1Novo Nordisk A/SNCT06433661Written as Etavopivat
Given in every arm · 1 — etavopivat is usual care beside what is tested
Codes
What other systems call etavopivat · ClinicalTrials.gg INT018198
- UNII (FDA) V4E0A9M44QETAVOPIVATOne source FDA
- NCI Thesaurus C176893EtavopivatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | V4E0A9M44Q | ETAVOPIVAT | One source FDA |
| NCI Thesaurus | C176893 | Etavopivat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.